Cost-Benefit Analysis of Second-Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer Disease
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.